Fiche du document
2014
- doi: 10.1093/ejcts/ezt364
- issn: 1010-7940
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/ejcts/ezt364
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/23847181
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1010-7940
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1873-734X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_DD3D9247FB199
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Citer ce document
E. Ferrari et al., « On-pump fibrillating heart mitral valve replacement with the SAPIEN? XT transcatheter heart valve. », Serveur académique Lausannois, ID : 10.1093/ejcts/ezt364
Métriques
Partage / Export
Résumé
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter aortic valve, who develop calcific mitral disease, would benefit from the development of new, minimally invasive, transcatheter or hybrid techniques for mitral valve replacement. In particular, mixing transcatheter valve therapies and well-established minimally invasive techniques for mitral replacement or repair can help in decreasing the surgical risk and the technical complexity. Thus, placing transcatheter, balloon-expandable Sapien? XT stent-valves in calcified, degenerated mitral valves through a right thoracotomy, a left atriotomy and on an on-pump fibrillating heart, represents an attractive alternative to standard surgery in redo patients, in patients with concomitant transcatheter aortic stent-valves in place and in patients with a high-risk profile. We describe this hybrid technique in detail.